GW Henssler & Associates Ltd. cut its position in shares of Procter & Gamble Co (NYSE:PG) by 4.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 150,337 shares of the company’s stock after selling 6,561 shares during the period. Procter & Gamble accounts for about 1.7% of GW Henssler & Associates Ltd.’s investment portfolio, making the stock its 19th largest position. GW Henssler & Associates Ltd.’s holdings in Procter & Gamble were worth $16,537,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Belmont Capital LLC bought a new position in shares of Procter & Gamble during the 4th quarter worth approximately $34,000. Efficient Wealth Management LLC bought a new position in shares of Procter & Gamble during the 1st quarter worth approximately $39,000. Wealthcare Capital Management LLC lifted its position in shares of Procter & Gamble by 126.0% during the 4th quarter. Wealthcare Capital Management LLC now owns 339 shares of the company’s stock worth $42,000 after buying an additional 189 shares during the period. Pacifica Partners Inc. bought a new position in shares of Procter & Gamble during the 4th quarter worth approximately $44,000. Finally, Lighthouse Financial Advisors Inc. bought a new position in shares of Procter & Gamble during the 4th quarter worth approximately $44,000. 64.03% of the stock is owned by institutional investors.
Several brokerages have issued reports on PG. Royal Bank of Canada reiterated a “hold” rating and issued a $120.00 price objective on shares of Procter & Gamble in a research report on Tuesday, April 14th. Jefferies Financial Group upgraded Procter & Gamble from a “hold” rating to a “buy” rating and cut their price objective for the company from $130.00 to $128.00 in a research report on Monday, March 30th. Citigroup lifted their price objective on Procter & Gamble from $143.00 to $146.00 and gave the company a “buy” rating in a research report on Monday, April 20th. Argus upgraded Procter & Gamble from a “hold” rating to a “buy” rating and set a $120.00 price objective for the company in a research report on Thursday, March 26th. Finally, TheStreet raised Procter & Gamble from a “c+” rating to a “b” rating in a research note on Tuesday, April 14th. Six investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Procter & Gamble currently has an average rating of “Buy” and a consensus price target of $130.31.
In other news, Director Nelson Peltz sold 3,500,000 shares of the business’s stock in a transaction dated Friday, April 24th. The stock was sold at an average price of $119.21, for a total value of $417,235,000.00. Following the sale, the director now directly owns 3,891 shares in the company, valued at $463,846.11. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Deborah P. Majoras sold 12,589 shares of the business’s stock in a transaction dated Monday, April 20th. The shares were sold at an average price of $122.68, for a total value of $1,544,418.52. Following the completion of the sale, the insider now owns 44,948 shares in the company, valued at $5,514,220.64. The disclosure for this sale can be found here. Over the last three months, insiders sold 7,392,511 shares of company stock valued at $887,693,596. Insiders own 1.75% of the company’s stock.
Shares of Procter & Gamble stock traded up $0.19 during trading on Wednesday, reaching $117.08. 8,702,545 shares of the company were exchanged, compared to its average volume of 10,756,886. The company has a quick ratio of 0.66, a current ratio of 0.83 and a debt-to-equity ratio of 0.52. Procter & Gamble Co has a twelve month low of $94.34 and a twelve month high of $128.09. The business has a 50-day moving average price of $114.28 and a 200-day moving average price of $120.89. The firm has a market capitalization of $290.76 billion, a price-to-earnings ratio of 66.04, a P/E/G ratio of 3.31 and a beta of 0.41.
Procter & Gamble (NYSE:PG) last posted its earnings results on Friday, April 17th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.13 by $0.04. Procter & Gamble had a return on equity of 29.15% and a net margin of 7.09%. The firm had revenue of $17.21 billion during the quarter, compared to analysts’ expectations of $17.29 billion. During the same period in the previous year, the firm earned $1.06 earnings per share. The company’s revenue was up 4.6% on a year-over-year basis. On average, equities research analysts forecast that Procter & Gamble Co will post 4.95 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 24th will be paid a $0.7907 dividend. This represents a $3.16 dividend on an annualized basis and a yield of 2.70%. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.75. The ex-dividend date of this dividend is Thursday, April 23rd. Procter & Gamble’s payout ratio is presently 69.91%.
About Procter & Gamble
The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.
Featured Article: How to interpret Moving Average Convergence Divergence (MACD)
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Co (NYSE:PG).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.